Ultragenyx Pharmaceutical
RARE
#5350
Rank
NZ$2.78 B
Marketcap
NZ$28.25
Share price
2.75%
Change (1 day)
-53.92%
Change (1 year)

P/S ratio for Ultragenyx Pharmaceutical (RARE)

P/S ratio as of October 2026 (TTM): 2.21

According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -5.58. At the end of 2026 the company had a P/S ratio of 4.23.

P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.2324.93%
20253.38-52.74%
20247.16-20.85%
20239.041.15%
20228.94-45.19%
202116.3-51.73%
202033.841.86%
201923.8-44.54%
201842.9-94.32%
2017756-96.5%
2016> 1000
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Lexicon Pharmaceuticals
LXRX
15.6 603.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-11.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.17 43.32%๐Ÿ‡บ๐Ÿ‡ธ USA